NALRIFOX showed numerically better overall survival vs FOLFIRINOX as frontline treatment in PDAC, per real-world analysis ...

NDAQ:IMRX) Immuneering Provides Positive Update on Phase 2a Arm Studying IMM-1-104 in Combination with Modified FOLFIRINOX ...

Single-agent adjuvant chemotherapy did not improve overall survival when compared to no adjuvant chemotherapy.

As of January 6, 2025, six evaluable patients were enrolled in the Phase 2a study of IMM-1-104 in combination with modified FOLFIRINOX or mFFX for first-line pancreatic cancer. Among which ...

Adjuvant combination leucovorin calcium, fluorouracil, irinotecan hydrochloride, and oxaliplatin (FOLFIRINOX) and other multiagent chemotherapy regimens boost overall survival (OS) in patients ...

Alligator Bioscience has announced positive outcomes from indirect treatment comparison studies, showing that mitazalimab ...

Association of malnutrition at diagnosis with survival among older adults with pancreatic cancer. This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal Cancers Symposium. This abstract ...

Regimen FOLFIRINOX FOLFOX —> FOLFIRI FOLFOX —> Liposomal Irinotecan/5-FU Liposomal Irinotecan/5-FU —>FOLFOX ...

Preclinical development of the lipid nanoparticle–based mRNA vaccine with multiple natural T cell epitopes for pancreatic cancer. This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal ...

Detailed price information for Oncolytics Biotech Inc (ONCY-Q) from The Globe and Mail including charting and trades.

此外，截至2024年12月5日，在IMM-1-104联合FOLFIRINOX化疗组合一线治疗胰腺癌的患者队列中，所有可评估患者（n=4）均实现了目标肿瘤缩小和疾病控制 ...

“We are thrilled to report two more responses in our Phase 2a arm studying IMM-1-104 in combination with modified FOLFIRINOX in first-line pancreatic cancer,” said Ben Zeskind, Ph.D., CEO of ...